BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10706453)

  • 1. Marrow cytokine transcripts and the secondary hematologic disorders.
    Preisler HD; Gao XZ; Ming T; Li B; Bi S; Devemy E; Loew J; Raza A
    Leuk Lymphoma; 1999 Oct; 35(3-4):297-302. PubMed ID: 10706453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
    Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
    Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
    Dunphy CH; O'Malley DP; Perkins SL; Chang CC
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):154-9. PubMed ID: 17525626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat.
    Hisasue M; Nagashima N; Nishigaki K; Fukuzawa I; Ura S; Katae H; Tsuchiya R; Yamada T; Hasegawa A; Tsujimoto H
    Int J Cancer; 2009 Mar; 124(5):1133-41. PubMed ID: 19035458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
    Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
    Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinase-9 in plasma of bone marrow aspirates of patients with acute myeloid leukemia and myelodysplastic syndrome].
    Lesnichenko IF; Kostroma II; Gritsaev SV; Chechetkin AV; Abdulkadyrov KM
    Vopr Onkol; 2016; 62(1):101-3. PubMed ID: 30444586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of myeloid differentiation antigens on myeloblasts in bone marrow of patients with myelodysplastic syndromes.
    Borbenyi Z; Ghosh A; Cinkotai K; Balogh E; Moore M
    Biomed Pharmacother; 1987; 41(2):101-4. PubMed ID: 3475134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic characteristics of acute leukemia after myelodysplastic syndrome.
    Masuya M; Kita K; Shimizu N; Ohishi K; Katayama N; Sekine T; Otsuji A; Miwa H; Shirakawa S
    Blood; 1993 Jun; 81(12):3388-94. PubMed ID: 7685204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
    Tuzuner N; Cox C; Rowe JM; Bennett JM
    Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).
    Bennett JM; Tuechler H; Aul C; Strupp C; Germing U
    Leuk Res; 2016 Aug; 47():63-9. PubMed ID: 27258735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments.
    Zhou T; Perez SN; Cheng Z; Kinney MC; Lemieux ME; Scott LM; Rebel VI
    PLoS One; 2016; 11(7):e0158649. PubMed ID: 27427906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
    Raza A; Yousuf N; Bohkari SA; Sheikh Y; Akhtar S; Chughtai S; Umerani A; Mehdi SA; Miller MA; Masterson M
    Leuk Res; 1992; 16(3):299-306. PubMed ID: 1560677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
    Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.